Approval · Notice of Compliance 19264 · 2017
PLEGRIDY: Notice of Compliance 19264
Issued May 4, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19264
- Date
- May 4, 2017
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing facility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLEGRIDY | Not yet assigned | — |
| PLEGRIDY (STARTER KIT) | Not yet assigned | — |
Medicinal ingredients
- PEGINTERFERON BETA-1A 63 MCG per 0.5ML
- PEGINTERFERON BETA-1A 94 MCG per 0.5ML
- PEGINTERFERON BETA-1A 125 MCG per 0.5ML